Varian Medical Systems Inc's Suppliers recorded an increase in sales by 9.95 % year on year in Q1 2020, sequentially sales grew by 10.32 %, Varian Medical Systems Inc's cost of sales deteriorated by -9.15 % year on year, relative to one quarter ago cost of sales fell by -11.77 % in Q1.
Varian Medical Systems Inc's Suppliers recorded an increase in sales by 9.95 % year on year in Q1 2020, sequentially sales grew by 10.32 %, Varian Medical Systems Inc's cost of sales deteriorated by -9.15 % year on year, compare to one quarter ago cost of sales fell by -11.77 % in Q1.
Varian Medical Systems Inc's Comment on Supply Chain
We manufacture our medical linear accelerators in Palo Alto, California and in
Beijing, China. Our treatment simulator systems and some accelerator subsystems
are manufactured in Crawley, United Kingdom and some of our other accessory products
in Baden, Switzerland; Helsinki, Finland; Toulouse, France and Winnipeg, Canada.
We manufacture our high dose rate brachytherapy systems in Crawley, United Kingdom
and Haan, Germany and our brachytherapy treatment planning products in Charlottesville,
Virginia. Calypso manufactures components of their tumor tracking and motion management
products in Seattle, Washington. Our security and inspection linear accelerators
are principally manufactured in Las Vegas, Nevada. We manufacture components and
sub-systems for our proton therapy products and systems in Troisdorf, Germany.
We manufacture our X-ray imaging component products in Salt Lake City, Utah; Charleston,
South Carolina; Liverpool, New York; Willich, Germany and Beijing, China. These
facilities employ state-of-the-art manufacturing techniques, and several have
been honored by the press, governments and trade organizations for their commitment
to quality improvement. These manufacturing facilities are certified by International
Standards Organization (“ISO”) under ISO 9001 (for security and inspection
products) or ISO 13485 (for medical devices).
Manufacturing processes at our various facilities include machining, fabrication,
subassembly, system assembly and final testing. We have invested in various automated
and semi-automated equipment for the fabrication and machining of the parts and
assemblies that we incorporate into our products. We may, from time to time, invest
further in such equipment. Our quality assurance program includes various quality
control measures from inspection of raw materials, purchased parts and assemblies
through on line inspection. We outsource the manufacturing of many major subassemblies
and perform system design, assembly and testing in house. We believe outsourcing
enables us to reduce or maintain fixed costs and capital expenditures, while also
providing us with the flexibility to increase production capacity. We purchase
material and components from various suppliers that are either standard products
or customized to our specifications. We obtain some of the components included
in our products from a limited group of suppliers or from a single source supplier,
such as the radioactive sources for high dose afterloaders, klystrons for linear
accelerators; transistor arrays and cesium iodide coatings for flat panel detectors
and specialized integrated circuits, X-ray tube targets, housings, glassframes
and various other components; and radiofrequency components, magnets and gantry
hardware for proton therapy systems. We require certain raw materials such as
tungsten, lead and copper for Oncology Systems and security and inspection products;
copper, lead, tungsten, rhenium, molybdenum zirconium, and various high grades
of steel alloy for X-ray tubes, and high-grade steel, high-grade copper and iron
for the VPT business. Worldwide demand, availability and pricing of these raw
materials have been volatile, and we expect that availability and pricing will
continue to fluctuate in the future.
Varian Medical Systems Inc's Comment on Supply Chain
We manufacture our medical linear accelerators in Palo Alto, California and in
Beijing, China. Our treatment simulator systems and some accelerator subsystems
are manufactured in Crawley, United Kingdom and some of our other accessory products
in Baden, Switzerland; Helsinki, Finland; Toulouse, France and Winnipeg, Canada.
We manufacture our high dose rate brachytherapy systems in Crawley, United Kingdom
and Haan, Germany and our brachytherapy treatment planning products in Charlottesville,
Virginia. Calypso manufactures components of their tumor tracking and motion management
products in Seattle, Washington. Our security and inspection linear accelerators
are principally manufactured in Las Vegas, Nevada. We manufacture components and
sub-systems for our proton therapy products and systems in Troisdorf, Germany.
We manufacture our X-ray imaging component products in Salt Lake City, Utah; Charleston,
South Carolina; Liverpool, New York; Willich, Germany and Beijing, China. These
facilities employ state-of-the-art manufacturing techniques, and several have
been honored by the press, governments and trade organizations for their commitment
to quality improvement. These manufacturing facilities are certified by International
Standards Organization (“ISO”) under ISO 9001 (for security and inspection
products) or ISO 13485 (for medical devices).
Manufacturing processes at our various facilities include machining, fabrication,
subassembly, system assembly and final testing. We have invested in various automated
and semi-automated equipment for the fabrication and machining of the parts and
assemblies that we incorporate into our products. We may, from time to time, invest
further in such equipment. Our quality assurance program includes various quality
control measures from inspection of raw materials, purchased parts and assemblies
through on line inspection. We outsource the manufacturing of many major subassemblies
and perform system design, assembly and testing in house. We believe outsourcing
enables us to reduce or maintain fixed costs and capital expenditures, while also
providing us with the flexibility to increase production capacity. We purchase
material and components from various suppliers that are either standard products
or customized to our specifications. We obtain some of the components included
in our products from a limited group of suppliers or from a single source supplier,
such as the radioactive sources for high dose afterloaders, klystrons for linear
accelerators; transistor arrays and cesium iodide coatings for flat panel detectors
and specialized integrated circuits, X-ray tube targets, housings, glassframes
and various other components; and radiofrequency components, magnets and gantry
hardware for proton therapy systems. We require certain raw materials such as
tungsten, lead and copper for Oncology Systems and security and inspection products;
copper, lead, tungsten, rhenium, molybdenum zirconium, and various high grades
of steel alloy for X-ray tubes, and high-grade steel, high-grade copper and iron
for the VPT business. Worldwide demand, availability and pricing of these raw
materials have been volatile, and we expect that availability and pricing will
continue to fluctuate in the future.
VAR's Suppliers Net Income grew by
VAR's Suppliers Net margin grew in Q1 to
1594.16 %
11.74 %
VAR's Suppliers Net Income grew by 1594.16 %
VAR's Suppliers Net margin grew in Q1 to 11.74 %
Varian Medical Systems Inc's Suppliers Sales Growth
in Q1 2020 by Industry
Sources:
Varian Medical Systems Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Varian Medical Systems Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2.03 % 